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The study aim was to establish the prevalence of DEA 1, the most immunogenic and clinically important blood group in canine
blood transfusion, in 7,414 dogs from Italy. The potential sensitization risk following a first transfusion and the acute reaction
risk following a second transfusion given without a cross-matching and blood typing test were also calculated. Dogs tested were
purebred (4,798) and mongrel (2,616); 38.8% were DEA 1 negative and 61.2% were DEA 1 positive. High prevalence for DEA 1
positive blood type was found in Ariegeois and English Setter, whereas German Shepherd and Boxer had higher DEA 1 negative
blood type. Breeds with blood type never reported before included French Brittany Spaniel and Pug showing a high prevalence
of DEA 1 positive type, while French Bulldog and West Highland White Terrier were more often DEA 1 negative. Just 48.8% of
purebred and 13.9% of mongrel dogs were considered as prospective blood donors based upon their blood type. Most of the breeds
had a sensitization risk of 20.0–25.0%. Rottweiler and Ariegeois had less risk of sensitization (9.4 and 4.2%) and the minor risk of
an acute transfusional reaction (0.9–0.2%).The prevalence of DEA 1 positive and negative dogs in Italy agrees with most of the data
already reported in the literature.
1. Introduction
Canine blood groups are recognized and have standardized
terminology as Dog Erythrocyte Antigen (DEA). The DEA
system includes seven well-known blood groups (DEA 1, 3,
4, 5, 6, 7, and 8) with over twenty antigen specificities [1–4].
Other nonstandardized antigens within DEA such as Dal [3,
5] and the recently described Kai 1 and 2 have been reported
[6]. Canine blood groups comprise a two-allele system with a
positive and negative type.
The DEA 1 blood group system initially was described
with 3 types, DEA 1.1, 1.2, and likely 1.3 [3, 7, 8]. Utiliz-
ing quantitative flow cytometry and an immunochromato-
graphic technique with a monoclonal anti-DEA 1 alloanti-
body the continuum of DEA 1 negative to weakly (1+) up
to strongly DEA 1 positive (4+) blood type was observed in
contrast to the originally described DEA 1 system and with
a significant correlation between these tests [9]. Recently, an
autosomal dominant mode of inheritance of 4 alleles of DEA
1 with strong (4+) to weak (1+) reactivity was discovered.
DEA 1 positive alleles are dominant overDEA 1 negative allele
without any direct correlation with the historical DEA 1.2
positive subtype [10]. So now, it is accepted to speak about
the DEA 1 group as a whole without any subtype [9, 10].
Natural occurring antibodies against DEA 1 antigen in
dog’s erythrocytes have never been positively identified [11].
On the other hand, natural antibodies against DEA 3, 5, and
7 have been documented with a prevalence of 6%, 23%, and
45%, respectively [2]. However, although all canine blood
group antigens can stimulate the formation of alloantibodies,
DEA 1 seems to be the most immunogenic and also is
considered the most clinically important. Alloantibodies will
appear following the first transfusion in DEA 1 negative
recipient dogs receiving positive DEA 1 red blood cells
(RBCs)within 4–14 days [11–14]. Sensitization of the recipient
and production of alloantibodies can result in a severe acute
hemolytic transfusion reaction and even death if a second
DEA 1 positive RBC transfusion is administered to the same
patient [15–17]. The risk of alloantibody production and
transfusion reactions against antigens other than DEA 1 is
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not yet well defined [2] and there is no documented clinical
evidence of a hemolytic reaction caused by DEA 1.2, 3, 5, and
7 in mismatched transfusions [18].
Blood typing to identify the presence of DEA 1 and
the cross-match to establish full compatibility should be
performed before each transfusion in order to reduce the risk
of sensitization or immunological reaction between donor
and recipient dogs [2, 19, 20]. Available methods for typing
DEA 1.1 antigen include agglutination cards (RapidVet-H,
Agrolabo, Scarmagno, TO, Italy) and an immunochromato-
graphic strip for DEA 1 (Quick Test DEA 1, Alvedia, Lyon,
France) both using monoclonal antibodies and are useful for
in-clinic testing [17, 21]. A gel column agglutination test using
microtubes is generally reserved for use in laboratory settings.
The advantage of gel column typing is the ability to establish
the degree of agglutination that can be graded from 0 to 4+. A
DEA 1.1 positive result is considered if the reaction is graded
as ≥2+ [17, 18, 22].
Theknowledge of breed differences for prevalence ofDEA
1 is very important for the recruitment of typed compatible
blood donors. DEA 1 is expressed approximately in 40–60%
of the general canine population. The prevalence of canine
blood group DEA 1 has been studied in small populations in
geographically restricted areas [23–28]. The most frequently
studied breeds were German Shepherd, Golden Retriever,
Greyhound, Doberman, and Rottweiler along with investiga-
tions in mongrel dogs [4, 18, 28–30].
The aim of our study was to determine the prevalence
of blood type DEA 1 in a large population database of
purebred and mongrel dogs reared in Italy. Furthermore,
we calculated the potential risk of sensitization following a
first transfusion and the subsequent risk of an acute transfu-
sional reaction as documented immune-mediated hemolysis
and/or agglutination following the second transfusion in the
absence of a pretransfusional cross-match and blood typing
test.
2. Material and Methods
The population of this study included 7,414 dogs retrieved
from the Italian database of the website Dog blood Donors
(DbD) (http://www.dogblooddonors.it). The data collected
were recorded in the website during the period of October
2014–July 2016.The following information has been extracted
from the DbD database: date of the dog’s registration on the
website, breed, weight, sex, year of birth, age, type of blood
group (negative or positive DEA 1), and the Italian regions
where the dogwas living at the time of registration.Dogswere
enrolled by private practitioners who recorded the above data
into the DbD website.
DEA 1 blood type was established using two commercial
in-clinic typing tests: RapidVet-H, Canine DEA 1.1, Agrolabo
(Scarmagno, TO, Italy), and Quick TEST DEA 1 Alvedia
(Lyon, France, distributed in Italy by Alcyon Italy, Marene,
CN). Both tests use a monoclonal antibody, the former in
an agglutination assay and the latter in immunochromato-
graphic strips. Dogs were typed using one of the two in-clinic
tests. Nevertheless, the RapidVet-H Canine DEA 1.1 test was
the one most used in up to 95% of the dogs.
The data collected from the website DbD has been orga-
nized as follows:
(i) The prevalence of DEA 1 negative and positive types
in the total population and in breeds that showed a
substantial number of subjects registered (over 50)
was calculated.
(ii) The breeds numbering over 50 subjects was subtyped
as females andmales and the prevalence of DEA 1 was
calculated according to sex.
(iii) In the breeds numbering over 50 subjects the percent-
age of the breed’s population was determined in
relation to the total Italian canine population inferred
from the last 10 years of registration at the ENCI (Ente
Nazionale di Cinofilia Italiana, Italian National Ken-
nel Club) (http://www.enci.it) which was calculated.
(iv) The data concerning the provenience and corre-
sponding blood type of the 7,414 dogs was subdivided
into different geographical regions of Italy.
(v) Using the standard inclusion criteria for canine blood
donors (dogs heavier than 25 kg and aged between
2 and 8 years) and breeds numbering over 20 sub-
jects were considered as prospective “blood donors”
regardless of whether they were DEA 1 positive or
negative.
(vi) The risk of sensitization for each breed (over 50 sub-
jects) was calculated using the formula [(% DEA 1
negative × % DEA 1 positive)/100] to establish the
probability of a dog to become sensitized after the first
transfusion of blood without having been tested with
a cross-match and typed for DEA 1 [28, 30, 31].
(vii) Using the following formula [(% DEA 1 negative × %
DEA 1 positive) × (% sensitization for the first trans-
fusion/10,000)] the probability of each breed (over 50
subjects) to develop an acute hemolysis and/or agglu-
tination (immune-mediated) transfusional reaction
with a second incompatible transfusion using un-
cross-matched and untyped blood was calculated [28,
30, 31].
(viii) The Excel 2016 software (Microsoft Office) was used
for data analysis.
3. Results
In Table 1, the prevalence ofDEA 1 negative and positive types
in the canine population registered in the database of the
DbD website in Italy (breeds represented by over 50 dogs)
is reported. The prevalence of DEA 1 negative and positive
types in breeds with less than 50 subjects and the complete
list of breeds are not shown.
In Table 2, the prevalence of DEA 1 negative and positive
types for females andmales for breeds represented by over 50
dogs is reported.
In Table 3, the percentage of breed’s population in relation
to the total Italian canine population inferred from the last 10
years of registration at the ENCI for the breeds numbering
over 50 subjects is reported.
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Table 1: Prevalence of DEA 1 negative and positive in the breeds.
Breeds Dogs tested DEA 1 neg DEA 1 pos
No. No. (%) No. (%)
Mixed 2,616 924 (35.3) 1,692 (64.7)
Labrador Retriever 478 166 (34.7) 312 (65.3)
German Shepherd 312 253 (81.1) 59 (18.9)
Golden Retriever 214 53 (24.8) 161 (75.2)
Jack Russell Terrier 213 100 (46.9) 113 (53.1)
Zwergpinscher 194 62 (32.0) 132 (68.0)
Chihuahua 164 64 (39.0) 100 (61.0)
English Cocker Spaniel 158 55 (34.8) 103 (65.2)
American Staffordshire Terrier 153 72 (53.1) 81 (46.9)
Dachshund 149 35 (25.8) 114 (74.2)
Poodle 144 45 (31.3) 99 (68.8)
Maltese 130 59 (45.4) 71 (54.6)
English Setter 126 24 (19.0) 102 (81.0)
Border Collie 124 66 (53.2) 58 (46.8)
Beagle 123 61 (49.6) 62 (50.4)
Yorkshire Terrier 108 40 (37.0) 68 (63.0)
Boxer 106 88 (83.0) 18 (17.0)
Cavalier King Charles Spaniel 103 53 (51.5) 50 (48.5)
Ariegeois 92 4 (4.3) 88 (95.7)
French Bulldog 86 67 (77.9) 19 (22.1)
French Brittany Spaniel 83 19 (22.9) 64 (77.1)
Shih Tzu 79 22 (27.8) 57 (72.2)
Cane Corso 76 38 (50.0) 38 (50.0)
Pug 61 14 (23.0) 47 (77.0)
Rottweiler 57 6 (10.5) 51 (89.5)
English Springer Spaniel 54 14 (25.9) 40 (74.1)
West Highland White Terrier 54 34 (63.0) 20 (37.0)
Other∗ 1,159 440 (38.0) 719 (62.0)
Total 7,414 2,878 (38.8) 4,536 (61.2)
∗Breed represented by less than 50 dogs. neg, negative, pos, positive, No., total number, and%, percentage (according to raw data retrieved from http://www
.dogblooddonors.it website).
In Table 4, the prevalence of prospective blood donors
(PBD), using inclusion standard criteria for canine blood
donors (including dogs heavier than 25 kgs and aged between
2 and 8 years) is reported. Only breeds with more than 20
subjects were considered.
In Table 5 the risk of sensitization following the first
transfusion and the risk of an acute transfusional reaction
documented as hemolysis and/or agglutination (immune-
mediated) following the second transfusion in the absence of
pretransfusional cross-match and blood typing test according
to the most involved breeds were shown.
In Figure 1 the distribution ofDEA 1 negative and positive
types in the several Italians regions is shown.
4. Discussion
This paper reports the largest study among the references
available on DEA 1 blood group prevalence to date. In
addition, is also includes the DEA 1 prevalence in breeds
never reported before. Indeed, a high number of purebred
canine subjects have been tested here, and the results provide
substantial information about the prevalence of DEA 1 blood
group in Italy, which could be useful not only in transfusion
medicine but also for canine genetic epidemiologic studies.
To obtain themost reliable results about the prevalence of
DEA 1 in the canine purebred population in Italy, only breeds
represented by over 50 dogs were analyzed. The prevalence
of PBD in purebred and mixed dog’s breeds represented by
more than 20 subjects also was examined. Of total 7,414
dogs tested (purebreds 4,798, mongrel 2,616) 2,878 (38.8%)
were DEA 1 negative and 4,536 (61.2%) were DEA 1 positive
(Table 1).Theprevalence forDEA 1 positive dogs found in this
study was very similar to results 553/890 (62.0%) reported in
another study carried out in Italy [29]. Furthermore, there
have been other studies that showed similar results for DEA 1
positive dogs as in the case of Nigeria 71/178 (60.1%), Turkey
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Table 2: Prevalence of DEA 1 negative and positive in female and male dogs.
Breeds
Dogs tested DEA 1 neg DEA 1 pos
Females Males Females Males
No. No. (%) No. (%) No. (%) No. (%)
Mixed 2,616 475 (51.4) 449 (48.6) 895 (52.9) 797 (47.1)
Labrador Retriever 478 80 (48.2) 86 (51.8) 160 (51.3) 152 (48.7)
German Shepherd 312 120 (47.4) 133 (52.6) 25 (42.4) 34 (57.6)
Golden Retriever 214 33 (62.3) 20 (37.7) 85 (52.8) 76 (47.2)
Jack Russell Terrier 213 4 8 (41.0) 59 (59.0) 54 (47.8) 59 (52.2)
Zwergpinscher 194 28 (45.2) 34 (54.8) 66 (50.0) 66 (50.0)
Chihuahua 164 32 (50.0) 32 (50.0) 46 (46.0) 54 (54.0)
English Cocker Spaniel 158 28 (50.9) 27 (49.1) 52 (50.5) 51 (49.5)
American Staffordshire Terrier 153 37 (51.4) 35 (48.6) 37 (45.7) 44 (54.3)
Dachshund 149 21 (60.0) 14 (40.0) 58 (50.9) 56 (49.1)
Poodle 144 22(48.9) 23 (51.1) 40 (40.4) 59 (59.6)
Maltese 130 33 (55.9) 26 (44.1) 39 (54.9) 32 (45.1)
English Setter 126 12 (50.0) 12 (50.0) 38 (37.3) 64 (62.7)
Border Collie 124 37 (56.1) 29 (43.9) 32 (55.2) 26 (44.8)
Beagle 123 30 (49.2) 31 (50.8) 25 (40.3) 37 (59.7)
Yorkshire Terrier 108 20 (50.0) 20 (50.0) 36 (52.9) 32 (47.1)
Boxer 106 40 (45.5) 48 (54.5) 13 (72.2) 5 (27.8)
Cavalier King Charles Spaniel 103 20 (37.7) 33 (62.3) 15 (30.0) 35 (70.0)
Ariegeois 92 4 (100.0) 0 (0.0) 42 (47.7) 46 (52.3)
French Bulldog 86 29 (43.3) 38 (56.7) 8 (42.1) 11 (57.9)
French Brittany Spaniel 83 13 (68.4) 6 (31.6) 26 (41.9) 38 (61.3)
Shih Tzu 79 8 (36.4) 14 (63.6) 22 (38.6) 35 (61.4)
Cane Corso 76 15 (39.5) 23 (60.5) 22 (57.9) 16 (42.1)
Pug 61 6 (42.9) 8 (57.1) 19 (40.4) 28 (59.6)
Rottweiler 57 3 (50.0) 3 (50.0) 28 (54.9) 23 (45.1)
English Springer Spaniel 54 7 (50.0) 7 (50.0) 17 (42.5) 23 (57.5)
West Highland White Terrier 54 16 (47.1) 18 (52.9) 6 (30.0) 14 (70.0)
Other∗ 1,159 219 (49.8) 221 (50.2) 353 (49.1) 366 (50.9)
Total 7,414 1,429 (19.3) 1,449 (19.5) 2,259 (30.5) 2,277 (30.7)
∗Breed represented by less than 50 dogs; neg, negative, pos, positive, No., total number,%, percentage (according to raw data retrieved from http://www.dog-
blooddonors.it web site).
116/178 (65.2%), Portugal 156/274 (56.9%), and Spain 110/206
(53.4%) [4, 25, 28, 32]. Nevertheless, the first research about
blood groups distribution in dogs from 1961 reported a lower
prevalence of DEA 1 positive dogs 148/332 (44.6%) [13].
The difference here could reflect the effects of the ongoing
worldwide inbreeding and linebreeding practiced within the
more popular dog breeds over the ensuing years. A recent
study in easternAfrica reported asmuch as 78/100 (78.0%) for
DEA 1 positive dogs [33], representing the highest reported
prevalence for DEA 1 positive blood types. Unfortunately, the
paper did not report which breeds were included and the
canine population studied was quite small. It is well known
that the DEA 1 blood group distribution varies according to
the geographical area investigated [6].
The DEA 1 blood group in dogs has been studied mainly
for transfusional purposes. Transfusion reactions usually do
not occur following the first transfusion because naturally
occurring antibodies against DEA 1 are very rarely found in
dogs (<0.3% in a population of 2,500 dogs tested by Hale
and Werfelmann) [34], unless they have been previously
sensitized by an incompatible transfusion. Regardless of this,
DEA 1 negative dogs should receive only DEA 1 negative
blood. If a negative DEA 1 dog is transfused with DEA 1
positive erythrocytes, an antibody reaction (agglutination
and/or hemolysis) can be elicited in the recipient [2].
The good clinical practice in canine transfusionmedicine
requires that both recipient and donor should be blood typed
for DEA 1, which is considered highly antigenic and the most
clinically relevant blood type [2, 35]. In addition, the cross-
match test is advisable to be carried out before a transfusion. If
a recipient receives consecutives transfusions of incompatible
blood, this patient could be highly sensitized and develop a
severe acute hemolytic reaction [15, 16].
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Table 3: Breeds in relation to the overall size of dog breed population according to the ENCI last 10 years of registration.
Breeds No. of dogs tested ENCI data %
Zwergpinscher 194 6,732 2.88
Yorkshire Terrier 108 7,664 1.41
Ariegeois 92 7,174 1.28
Shih Tzu 79 6,620 1.19
Maltese 130 12,816 1.01
Cavalier King Charles Spaniel 103 10,291 1.00
Poodle 144 15,185 0.95
French Bulldog 86 9,551 0.90
English Cocker Spaniel 158 20,528 0.77
West Highland White Terrier 54 7,297 0.74
Beagle 123 17,407 0.71
Pug 61 9,099 0.67
American Staffordshire Terrier 153 23,011 0.66
Labrador Retriever 478 77,116 0.62
Border Collie 124 23,101 0.54
Dachshund 149 28,108 0.53
Chihuahua 164 32,494 0.50
Jack Russell Terrier 213 46,221 0.46
Golden Retriever 214 49,580 0.43
Boxer 106 36,926 0.29
English Springer Spaniel 54 20,473 0.26
Cane Corso 76 31,296 0.24
German Shepherd 312 152,649 0.20
Rottweiler 57 30,350 0.19
French Brittany Spaniel 83 44,534 0.19
English Setter 126 145,906 0.09
ENCI: Italian National Kennel Club, No.: total number,%, percentage (according to raw data retrieved from http://www.dogblooddonors.it website).
Table 4: Number of prospective blood donors.
Breeds DEA 1 neg DEA 1 pos
∗PBD DEA neg DEA pos
No. No. (%) No. (%) No. No. (%) No. (%)
Labrador Retriever 478 166 (34.7) 312 (65.3) 264 105 (39.8) 159 (60.2)
German Shepherd 312 253 (81.1) 59 (18.9) 171 145 (84.8) 26 (15.2)
Golden Retriever 214 53 (24.8) 161 (75.2) 133 38 (28.6) 95 (71.4)
American Staffordshire Terrier 153 72 (53.1) 81 (46.9) 58 24 (41.4) 34 (58.6)
Boxer 106 88 (83.0) 18 (17.0) 66 56 (84.8) 10 (15.2)
Ariegeois 92 4 (4.3) 88 (95.7) 5 1 (20.0) 4 (80.0)
Cane Corso 76 38 (50.0) 38 (50.0) 27 17 (63.0) 10 (37.0)
Rottweiler 57 6 (10.5) 51 (89.5) 32 3 (9.4) 29 (90.6)
Bernese Mountain Dog 44 8 (18.2) 36 (81.8) 33 7 (21.2) 26 (78.8)
Dobermann 32 25 (78.1) 7 (21.9) 19 14 (73.7) 5 (26.3)
Kurzhaar 30 7 (23.3) 23 (76.7) 4 2 (50.0) 2 (50.0)
Australian Shepherd 29 9 (31.0) 20 (69.0) 3 0 (0.0) 3 (100.0)
Siberian Husky 29 12 (41.4) 17 58.6) 4 2 (50.0) 2 (50.0)
Maremma Sheepdog 24 12 (50.0) 12 (50.0) 15 7 (46.7) 8 (53.3)
Weimaraner 24 14 (58.3) 10 (41.7) 13 7 (53.8) 6 (46.2)
Belgian Shepherd 23 12 (52.2) 11 (47.8) 3 2 (66.7) 1 (33.3)
English Pointer 22 8 (36.4) 14 (63.6) 2 1 (50.0) 1 (50.0)
Total 1,745 787 (45.1) 958 (54.9) 852 431 (50.6) 421 (49.4)
∗PBD prospective blood donor based on age (2 to 8 years old) and body weight (>25 kg); neg, negative, pos, positive, No., total number, and %, percentage
(according to raw data retrieved from http://www.dogblooddonors.it website).
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Table 5:The risk of sensitization after 1st transfusion and the risk of
an acute hemolytic reaction after 2nd transfusion in the absence of
pretransfusional cross-match and blood typing test§.
Breeds
Sensitization risk
after 1st transfusion
(%)
Acute
immune-mediated
reaction after 2nd
transfusion (%)
Beagle 25.0 6.2
Cane Corso 25.0 6.3
Cavalier King Charles
Spaniel 25.0 6.2
American
Staffordshire Terrier 24.9 6.2
Border Collie 24.9 6.2
Jack Russell Terrier 24.9 6.2
Maltese 24.8 6.1
Chihuahua 23.8 5.7
West Highland White
Terrier 23.3 5.4
Yorkshire Terrier 23.3 5.4
Mixed 22.8 5.2
English Cocker
Spaniel 22.7 5.1
Labrador Retriever 22.7 5.1
Zwergpinscher 21.7 4.7
Poodle 21.5 4.6
Shih Tzu 20.1 4.0
English Springer
Spaniel 19.2 3.7
Dachshund 19.1 3.7
Golden Retriever 18.6 3.5
French Brittany
Spaniel 17.7 3.1
Pug 17.7 3.1
French Bulldog 17.2 3.0
English Setter 15.4 2.4
German Shepherd 15.3 2.4
Boxer 14.1 2.0
Rottweiler 9.4 0.9
Ariegeois 4.2 0.2
§According to raw data retrieved from http://www.dogblooddonors.it web-
site.
In this study a high prevalence for DEA 1 positive type in
breeds such as Rottweiler (89.5%), Golden Retriever (75.2%),
and Dachshund (74.2%) was reported. These results are
comparable to those found in other previous investigations:
78.0–100% in Rottweiler, 77.0–95.0% in Golden Retriever,
and 71.0–100% in Dachshund [24, 28, 29, 36, 37]. It is
important to know the frequency of DEA 1 positive blood
type in the Rottweiler and Golden Retriever as they could be
enrolled as blood donors, because their weight is in the range
established for donations and they are generally docile dogs.
The high prevalence for breeds such as Ariegeois (95.7%),
English Setter (81.0%), and Zwergpinscher (80.0%) has been
confirmed according to the previous study carried out in Italy
[29].
In this study, the Labrador Retriever breed showed a high
prevalence for DEA 1 positive type (65.3%) as reported previ-
ously in studies carried out in Switzerland, South Africa, and
Italy [24, 29, 37]. Nevertheless, in the published study from
Portugal, Labrador Retrievers showed a higher prevalence for
DEA 1 negative type (55.0%), although those results could
be related to the low number of dogs (number 29) tested in
comparison to our data (number 478) [28].
The prevalence of DEA 1 positive type in English Cocker
Spaniel is 65.2%, in the Poodle 68.8%, and in Yorkshire
Terrier 63.0%. These values are different from those found
in other countries such as Switzerland which reported a high
prevalence for DEA 1 negative (67%) type in the Poodle and
in Portugal which reported 68.8% of DEA 1 negative type in
the English Cocker Spaniel [28, 37].
In this study, the ShihTzu breed showed a high prevalence
for DEA 1 positive type (72.2%), while, on the contrary, a
Japanese study reported an almost equal prevalence for DEA
1 positive (57%) and negative (43%) types in this breed. It
should be pointed out, however, that only a small number of
dogs (7) were tested in the Japanese study [38].
A high frequency for DEA 1 positive blood type has
been observed in breeds such as French Brittany Spaniel
(77.1%), Pug (77.0%), English Springer Spaniel (74.1%), and
Chihuahua (61.0%).These results cannot be compared due to
the absence of previous studies (Table 1).
In this study breeds with high DEA 1 negative preva-
lence were German Shepherd (81.1%), Boxer (83.0%), French
Bulldog (77.9%), and West Highland White Terrier (63.0%)
(Table 1). The high prevalence for DEA 1 negative type in
German Shepherd was similar to that found previously in
few countries such as South Africa (84.0%) [24], Portugal
(100%) [28], Brazil, and Italy (both 90.0%) [29, 36]. Almost
the same situation was observed in the Boxer, in addition to
South Africa (88.0%) [24], Portugal (100%) [28], Switzerland
(100%) [37], and Italy (80.0%) [29]. It is noteworthy that
DEA 1 negative frequencies in French Bulldog (77.9%) and
West Highland White Terrier (63.0%) were not previously
reported. A high prevalence of DEA 1 negative type could
be expected from the mating between female and male dogs
within the same blood line but it is unknown if these tested
dogs were the result of inbreeding or linebreeding. A recent
study showed that mating between DEA 1 negative dogs
strictly produced DEA 1 negative offspring, while mating
between DEA 1 positive dogs primarily resulted in DEA
1 positive offspring, with an occasional DEA 1 negative
offspring [10].
In our report, several breeds such as Jack Russell Terrier,
Beagle, Border Collie, and Maltese showed an almost equal
prevalence of DEA 1 negative and positive subjects. On the
other hand, in this study, the Cane Corso breed shows exactly
50.0% for both DEA 1 negative and positive subjects, and
these results are completely different from those obtained in
another study carried out in Italy (72.0% for DEA negative
type) [29]. The DEA 1 negative type prevalence reported in
South Africa for American Staffordshire Terrier was 75.0%
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Lombardia
Piemonte
Emilia Romagna
Toscana
Umbria
Veneto
Marche
Lazio
Liguria
Sardegna
Puglia
Sicilia
% DEA 1 neg 
% DEA 1 pos 
37.5
62.5
37.9
62.1
35.1
64.9
52.7
47.3 24.0 
76.0 
52.1
47.9
33.8
66.2
46.0
54.0
49.5
50.5
40.6
59.4
91.2
8.8
35.3
64.7
Regions Dog tested
Lombardia 3,697
Piemonte 1,025
Emilia Romagna 948
Toscana 493
Umbria 388
Veneto 330
Marche 145
Lazio 139
Liguria 111
Sardegna 64
Puglia 34
Sicilia 17
Other regions 23
Total 7,414
．
∘
Figure 1: Distribution of DEA 1 negative and positive dogs in Italians regions (according to raw data retrieved from http://www.dog-
blooddonors.it website).
which differs from the equal prevalence found in the current
study [24]. Another breed whose prevalence differs from
those found in this study is theMaltese breed which reported
a 33% for DEA 1 positive type in a study carried out on only 9
Maltese dogs in Japan [38]. The prevalence found in Cavalier
King Charles Spaniel (48.5% of DEA 1 positive and 51.5% of
DEA 1 negative types) dogs cannot be compared with any
previous study as far as we know (Table 1).
Differences in the DEA 1 frequency in various countries
are generally due to the selection of the population tested
and the genetic drift deriving from local breeding. It is
important to consider that in this study the sampling for
DEA 1 testingwas using dogs randomly accessed from several
veterinary facilities and privately owned. However, as the
blood type is a genetic marker, it should be considered as one
way to reveal the hybrid history of canine breeds supplying
information about migration and breed development in
the canine database of several countries. Of course, this
information is less accurate than the genomic data in the
phylogenetic analysis reported by Parker et al. (2017) [39].
Breeds such as French Brittany Spaniel, Pug, English
Springer Spaniel, and Chihuahua had a higher prevalence
for DEA 1 positive type. On the other hand, breeds that
had higher prevalence for DEA 1 negative type were French
Bulldog and West Highland White Terrier. So far, there are
no studies that report the DEA 1 prevalence for these breeds,
although it would be interesting to be able to compare these
results, even though we are not sure if the dogs included in
this study from matings between inbred or tightly linebred
dogs. Perhaps the fact that some of these dogs presented a
high percentage of positive or negative DEA 1 blood type
could be the result of matings between two DEA 1 negative
dogs that produced only DEA 1 negative offspring or matings
between DEA 1 positive dogs that resulted in DEA 1+ dogs,
with an occasional production of a DEA 1 negative dog [10].
Therewas nonotable difference in the prevalence forDEA
1 negative or positive type among females and males in this
study, except for females Boxers (13/18 DEA 1 positive dogs
were females), which represented 72.2%. The Cavalier King
Charles Spaniel (35/50 DEA 1 positive dogs were males) and
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WestHighlandWhite Terrier (14/20DEA 1 positive dogswere
males) both represented 70%. The Ariegeois breed females
had the highestDEA 1 negative (100%) type but only 4 females
were tested (Table 2). It would be interesting to know if
Ariegeois negative bitches had received blood transfusions so
they could become sensitized. In this occurrence, the mating
with aDEA 1 positive dog could raise the probability of risk of
neonatal isoerythrolysis in any DEA 1 positive offspring [2].
There are not any studies about the prevalence of DEA
1 negative or positive types in relation to sex and breed
except an investigation carried out in East Africa showing
generic similar result but in a very small population [33].
A previous study established that the DEA 1 blood group
system is an autosomal trait, with both male and female
dogs either being DEA 1 negative or having varying degrees
of DEA 1 positivity [10]. In addition, a survey ascertained
that female dogs, even after pregnancy, did not develop any
alloantibodies against RBC antigens during gestation, so they
can be used safely as blood donors [40]. Further, additional
pretransfusion compatibility testing is not required should
they require transfusions themselves.
The obtained percentages of purebred dogs tested for
DEA 1 in comparison to the numbers of these breeds enrolled
by ENCI in the last 10 years were more than 1.0% in Yorkshire
Terrier, Ariegeois, Shih Tzu, Maltese, and Cavalier King
Charles Spaniel, and a high consistency (almost 3.0%) was
noted in the Zwergpinscher breed (Table 3). These percent-
ages provide important genetic epidemiologic data for the
prevalence of DEA 1 in Italian purebred dogs.
The data compiled in the DbD website permitted us
to achieve the aims of the project in the several Italian
regions covered (Figure 1). The northern Italian regions were
apparently more aware of the need for blood donation in
dogs in comparison to the other Italian regions.This situation
seems to be the same in humans blood donors where a
higher percentage of donors were in regions such as Emilia
Romagna (3.2%), Marche (3.5%), and Lombardia (2.6%) [41].
In addition, the low number of enrolled dogs in southern
Italian regions could also be related to the low number of
dogs officially registered with amicrochip, since this data was
a mandatory requirement to enroll dogs in the DbD website.
The so-called “universal donor” dogs are generally accept-
ed as being negative for DEA 1, 3, 5, and 7 but positive only for
DEA 4. Usually DEA 3, 5, and 7 blood groups are not tested
because they do not show amajor transfusion reaction during
the first transfusion and there are difficulties in obtaining the
required blood typing antisera [2].
Anyhow, the prevalence of alloantibodies against blood
group antigens in dogs is quite rare and the only alloantibody
consistently found is against DEA 7 antigen (around 10% in
2,500 dogs tested), and so far evidence of transfusion reac-
tions or neonatal isoerythrolysis has not been documented
[17, 34, 40].
In this study, 852/1745 (48.8%) of the purebred dogs were
considered as PBD. A smaller number of PBD have been
found in the mixed breed dogs (304/2616, 13.9%) (Table 4).
The status of PBD was established using the standard inclu-
sion criteria for canine blood donors as data reported in the
DbD web page, namely, dogs being heavier than 25 kgs and
of ages between 2 and 8 years, regardless of whether they
were DEA 1 positive or negative and female or male (Table 4).
Obviously, due to their selection as PBD dogs the distribution
of DEA 1 negative and positive type is different from the
general population studied and reported in Table 1.
Most of the breeds in this study have the sensitization risk
ranging from 20.0 to 25.0% which means that the probability
of a dog to become sensitized following the first transfusion
of blood without having been tested with a cross-match
and typed for DEA 1 is quite high (Table 5). Rottweiler and
Ariegeois breeds had only a minor risk to become sensitized
and produce antibodies against DEA 1 following the first
transfusion (9.4 and 4.2%, resp.). These results are related to
the higher prevalence of DEA 1 positive type in these breeds
which reduced the risk of transfusional reactions. On the
other hand, Beagle, Cane Corso, and Cavalier King Charles
Spaniel had the highest percentage likelihood to become
sensitized (25.0%) (Table 5).
Regarding the risk of an acute transfusional reaction
documented as hemolysis and/or agglutination following the
second transfusion, Ariegeois and Rottweiler breed showed
the minor risk (0.2–0.9%). On the contrary Cane Corso,
Beagle, Cavalier King Charles Spaniel, American Stafford-
shire Terrier, Border Collie, Jack Russell Terrier, and Maltese
showed the highest risk (6.3 to 6.1%) (Table 5). Only a
few studies have reported the risk for sensitization of an
acute transfusional reaction. In 4 native breeds of Turkey a
high sensitization risk after the first transfusion (14.4–35.6%)
and the risk of an acute hemolytic reaction after second
transfusion (7.2–25.3%) were found [32]. In Ibizan Hound
and Galgos from Spain the sensitization risk after the first
transfusion was similar to the data reported here [4, 30].
A limitation of this study was the use of the two in-clinic
blood typing methods. Misclassification of blood typing
results could occur even if performed by an experienced
person [21]. Indeed, taking pictures of the results and storing
them for future needs are suggested, but we were not able to
have access to these rawdata. Considering the highnumber of
animals tested, however, even if a few errors in blood typing
classification occurred, they would not have influenced the
overall conclusions of the data presented. Finally, when used
in healthy dogs both assays gave almost equivalent results
[21].
Regardless of this, at present there is no a gold standard
for blood typing in dogs [16].TheQuick TESTDEA 1 Alvedia
and the RapidVet-H Canine DEA 1.1 are easy to use and
were performed by veterinary practitioners. Nevertheless,
the proper use and interpretation of the rapid typing test
RapidVet-H Canine DEA 1.1, which was largely used in this
study, were completed upon request by the Agrolabo, TO,
Italy technical support group [8, 21, 22, 42].
5. Conclusions
This study provides an overview about the distribution of
DEA 1 blood group in a large dog population belonging to
purebred and mongrel dogs reared in Italy. The data could
be useful in clinical transfusion medicine and for studies of
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canine genetic epidemiology. The prevalence of DEA 1 posi-
tive and negative dogsmostly agreeswith previous prevalence
studies reported in the literature. In addition, DEA 1 distri-
bution was studied in breeds never previously reported. The
risk of sensitization following the first transfusion and the risk
of an acute transfusional reaction documented as hemolysis
and/or agglutination following the second transfusion in the
absence of a pretransfusional cross-match and blood typing
test also was determined in most of the breeds studied.
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